BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

551 related articles for article (PubMed ID: 9026764)

  • 41. Advances in prophylaxis and therapy of Rh-erythroblastosis.
    Thomsen K
    Nihon Sanka Fujinka Gakkai Zasshi; 1969 Aug; 21(8):911-2. PubMed ID: 4186822
    [No Abstract]   [Full Text] [Related]  

  • 42. Transfusion medicine illustrated: blocked D phenomenon.
    Moiz B; Salman M; Kamran N; Shamsuddin N
    Transfusion; 2008 Aug; 48(8):1545-6. PubMed ID: 18713103
    [No Abstract]   [Full Text] [Related]  

  • 43. Sinusoidal fetal heart rate pattern following intrauterine fetal transfusion.
    Mueller-Heubach E; Caritis SN; Edelstone DI
    Obstet Gynecol; 1978 Jul; 52(1 Suppl):43S-46S. PubMed ID: 98743
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Severe Rh alloimmunization and hemolytic disease of the fetus managed with plasmapheresis, intravenous immunoglobulin and intrauterine transfusion: A case report.
    Houston BL; Govia R; Abou-Setta AM; Reid GJ; Hadfield M; Menard C; Noyd J; Main S; Zarychanski R
    Transfus Apher Sci; 2015 Dec; 53(3):399-402. PubMed ID: 26321100
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Management of the Rh-negative gravida.
    Charles AG
    Obstet Gynecol Annu; 1976; 5():167-75. PubMed ID: 824583
    [No Abstract]   [Full Text] [Related]  

  • 46. [Serologic incompatibility in a newborn infant caused by antigen C of the RH-HR blood-group system].
    Iwaszko-Krawczuk W; Kochańska-Leończak J; Dzienis K; Dabrowski S
    Acta Haematol Pol; 1988; 19(3-4):199-201. PubMed ID: 3150894
    [No Abstract]   [Full Text] [Related]  

  • 47. Intravenous immune globulin in the management of severe Rh D hemolytic disease.
    Porter TF; Silver RM; Jackson GM; Branch DW; Scott JR
    Obstet Gynecol Surv; 1997 Mar; 52(3):193-7. PubMed ID: 9061721
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The possibility of the use of Rh positive blood in the treatment of haemolytic disease of the newborn caused by Rh isoimmunization].
    Pataki L; Román F; Kaiser G; Virág I
    Orv Hetil; 1969 Aug; 110(34):1967-70. PubMed ID: 4981554
    [No Abstract]   [Full Text] [Related]  

  • 49. Management of Rh-immunized pregnancies.
    Queenan JT
    Prenat Diagn; 1999 Sep; 19(9):852-5. PubMed ID: 10521844
    [No Abstract]   [Full Text] [Related]  

  • 50. The experience and effectiveness of the Nova Scotia Rh program, 1964-84.
    Baskett TF; Parsons ML; Peddle LJ
    CMAJ; 1986 Jun; 134(11):1259-61. PubMed ID: 3011235
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relationship between obstetric history and Rh(D) alloimmunization severity.
    Lobato G; Soncini CS
    Arch Gynecol Obstet; 2008 Mar; 277(3):245-8. PubMed ID: 17763861
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Intrauterine intravascular transfusion--the effect of treatment on severe types of Rh isoimmunization].
    Radunović N; Lazarević B; Plećas D; Aleksić M; Popović M
    Srp Arh Celok Lek; 1988 Apr; 116(4):317-22. PubMed ID: 3142057
    [No Abstract]   [Full Text] [Related]  

  • 53. [Low-level rhesus alloimmunization and other alloimmunizations in pregnancy].
    Pellet B; Chessex D; Schneider P; Holfeld P
    Rev Med Suisse Romande; 1991 Aug; 111(8):693-9. PubMed ID: 1925243
    [No Abstract]   [Full Text] [Related]  

  • 54. Intrauterine transfusion in an Rh-immunized twin pregnancy: a case report of successful outcome and a review of the literature.
    Manning FA; Bowman JM; Lange IR; Chamberlain PF
    Obstet Gynecol; 1985 Mar; 65(3 Suppl):2S-6S. PubMed ID: 3919348
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rh-immunoglobulin: Rh prophylaxis.
    Bowman J
    Best Pract Res Clin Haematol; 2006; 19(1):27-34. PubMed ID: 16377539
    [No Abstract]   [Full Text] [Related]  

  • 56. Severe hemolytic disease of the newborn from anti-e.
    McAdams RM; Dotzler SA; Winter LW; Kerecman JD
    J Perinatol; 2008 Mar; 28(3):230-2. PubMed ID: 18309317
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Prenatal immunoglobulin prevention in Rh(D)-negative nonsensitized pregnant women].
    Katsulov A
    Akush Ginekol (Sofiia); 1997; 36(2):1-2. PubMed ID: 9471891
    [No Abstract]   [Full Text] [Related]  

  • 58. [Allo-immunization. 2: Its treatment and prevention].
    Bowman J; Lorrain J
    Union Med Can; 1984 Apr; 113(4):312-9. PubMed ID: 6428021
    [No Abstract]   [Full Text] [Related]  

  • 59. [The activation of the immunosorptive properties of blood during its UV irradiation at therapeutic doses].
    Vasil'eva ZF; Shtil'bans VI; Samoĭlova KS; Obolenskaia KD
    Biull Eksp Biol Med; 1989 Dec; 108(12):689-91. PubMed ID: 2517485
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Problems of the closed technique of intrauterine fetal transfusion.
    Friesen R
    Ann Ostet Ginecol Med Perinat; 1971 Sep; 92(9):543-9. PubMed ID: 4400491
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.